Stratification of Digestive Cancers with Different Pathological Features and Survival Outcomes by MicroRNA Expression

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Tang, Senwei ^a   Wu, William K K ^a   Li, Xiangchun ^a   Wong, Sunny H ^a   Wong, Nathalie ^a   Chan, Matthew T V ^a   Sung, Joseph J Y ^a   Yu, Jun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; TUMOR MARKER;

CANCER STAGING; CLUSTER ANALYSIS; COMPLICATION; DIGESTIVE SYSTEM NEOPLASMS; DISEASE COURSE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MICROSATELLITE INSTABILITY; MORTALITY; MUTATION; PROGNOSIS; SURVIVAL ANALYSIS; VIROLOGY;

BIOMARKERS, TUMOR; CLUSTER ANALYSIS; DIGESTIVE SYSTEM NEOPLASMS; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MICRORNAS; MICROSATELLITE INSTABILITY; MUTATION; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84964542736     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24466     Document Type: Article

References (43)

1. Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet-Tieulent, J. & Jemal, A. Global cancer statistics. 2012. CA Cancer J. Clin. 65, 87-108 (2015).
2. Wu, W. K. & Sung J. J. Focus on gastrointestinal and liver cancers. Semin. Cancer Biol. 23, 469-470 (2013).
3. Cancer Genome Atlas Research Network et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513, 202-209 (2014).
4. Lin, D. C. et al. Genomic and molecular characterization of esophageal squamous cell carcinoma. Nat. Genet. 46, 467-473 (2014).
5. Cancer Genome Atlas Network et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330-337 (2012).
6. Wong, S. H. et al. Genome-wide association and sequencing studies on colorectal cancer. Semin. Cancer Biol. 23, 502-511 (2013).
7. Cristescu, R. et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat. Med. 21, 449-456 (2015).
8. Yu, J. et al. Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer. Gut 64, 636-645 (2015).
9. Wu, W. K. et al. MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene 29, 5761-5771 (2010).
10. Wu, W. K. et al. MicroRNA in colorectal cancer: from benchtop to bedside. Carcinogenesis 32, 247-253 (2011).
11. Srivastava, S. K., Arora, S., Singh, S., Bhardwaj, A., Averett, C. & Singh, A. MicroRNAs in pancreatic malignancy: progress and promises. Cancer Lett. 347, 167-174 (2014).
12. Callegari, E., Gramantieri, L., Domenicali, M., D'Abundo, L., Sabbioni, S. & Negrini, M. MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches. Cell Death Differ. 22, 46-57 (2015).
13. Dong, Y. et al. MicroRNA dysregulation in colorectal cancer: a clinical perspective. Br. J. Cancer 104, 893-898 (2011).
14. Tang, G., Shen, X., Lv, K., Wu, Y., Bi, J. & Shen, Q. Different normalization strategies might cause inconsistent variation in circulating microRNAs in patients with hepatocellular carcinoma. Med. Sci. Monit. 21, 617-624 (2015).
15. Shrestha, S. et al. A systematic review of microRNA expression profiling studies in human gastric cancer. Cancer Med. 3, 878-888 (2014).
16. Gong, X. et al. Evaluating the consistency of differential expression of microRNA detected in human cancers. Mol. Cancer Ther. 10, 752-60 (2011).
17. Williams, Z. et al. Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations. Proc. Natl. Acad. Sci. USA 110, 4255-4260 (2013).
18. Law, P. T. et al. Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma. J. Hepatol. 58, 1165-1173 (2013).
19. Rosenfeld, N. et al. MicroRNAs accurately identify cancer tissue origin. Nat. Biotechnol. 26, 462-469 (2008).
20. Pobezinsky, L. A. et al. Let-7 microRNAs target the lineage-specific transcription factor PLZF to regulate terminal NKT cell differentiation and effector function. Nat. Immunol. 16, 517-524 (2015).
21. de la Rica, L. et al. NF-kappaB-direct activation of microRNAs with repressive effects on monocyte-specific genes is critical for osteoclast differentiation. Genome Biol. 16, 2 (2015).
22. Lu, D. et al. The miR-155-PU.1 axis acts on Pax5 to enable efficient terminal B cell differentiation. J. Exp. Med. 211, 2183-2198 (2014).
23. Quante, M. et al. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell 21, 36-51 (2012).
24. Kim, T. M., Laird, P. W. & Park, P. J. The landscape of microsatellite instability in colorectal and endometrial cancer genomes. Cell 155, 858-868 (2013).
25. Popat, S., Hubner, R. & Houlston, R. S. Systematic review of microsatellite instability and colorectal cancer prognosis. J. Clin. Oncol. 23, 609-618 (2005).
26. Singer, G. et al. Different types of microsatellite instability in ovarian carcinoma. Int. J. Cancer 112, 643-646 (2004).
27. Halling, K. C. et al. Origin of microsatellite instability in gastric cancer. Am. J. Pathol. 155, 205-211 (1999).
28. Zhang, W. et al. miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression. Neuro. Oncol. 14, 712-719 (2012).
29. Jo, W. S. & Carethers, J. M. Chemotherapeutic implications in microsatellite unstable colorectal cancer. Cancer Biomark. 2, 51-60 (2006).
30. Fallik, D. et al. Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer. Cancer Res. 63, 5738-5744 (2003).
31. King, C. E., Cuatrecasas, M., Castells, A., Sepulveda, A. R., Lee, J. S. & Rustgi, A. K. LIN28B promotes colon cancer progression and metastasis. Cancer Res. 71, 4260-4268 (2011).
32. Yue, B. et al. Long non-coding RNA FER1L4 suppresses oncogenesis and exhibits prognostic value by associating with miR-106a-5p in colon cancer. Cancer Sci. 106, 1323-1332 (2015).
33. Ak, S. et al. MicroRNA expression patterns of tumors in early-onset colorectal cancer patients. J. Surg. Res. 191, 113-122 (2014).
34. Kittaneh, M., Montero, A. J. & Gluck, S. Molecular profiling for breast cancer: a comprehensive review. Biomark. Cancer 5, 61-70 (2013).
35. Zhai, H., Fesler, A., Ba, Y., Wu, S. & Ju J. Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy. Oncotarget 6, 19735-19746 (2015).
36. Cai, L. & Cai, X. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma. Diagn. Pathol. 9, 1000 (2014).
37. Wang, W. Y. et al. miR-21 expression predicts prognosis in hepatocellular carcinoma. Clin. Res. Hepatol. Gastroenterol. 38, 715-719 (2014).
38. Su, Z. X., Zhao, J., Rong, Z. H., Geng, W. M., Wu, Y. G. & Qin, Q. K. Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma. Diagn. Pathol. 9, 47 (2014).
39. Wang, J., Li, J., Shen, J., Wang, C., Yang, L. & Zhang, X. MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma. BMC Cancer 12, 227 (2012).
40. Karaayvaz, M. et al. Prognostic significance of miR-215 in colon cancer. Clin. Colorectal Cancer 10, 340-347 (2011).
41. Li, J., Wang, Y., Yu, W., Chen, J. & Luo, L. Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance. Biochem. Biophys. Res. Commun. 406, 70-73 (2011).
42. Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).
43. Gao, Y. & Church, G. Improving molecular cancer class discovery through sparse non-negative matrix factorization. Bioinformatics 21, 3970-3975 (2005).